Winship Cancer Institute of Emory University

What Winship Cancer Institute of Emory University does

Winship Cancer Institute of Emory University is Georgia's only NCI-designated Comprehensive Cancer Center and an academic, nonprofit unit of Emory University, founded in 1937 with a gift from Coca-Cola President Robert W. Woodruff. Headquartered at 1365-C Clifton Road NE in Atlanta, Winship delivers comprehensive cancer care — prevention, detection, diagnosis, treatment, and survivorship — to more than 21,000 new patients annually across eight Emory Healthcare locations and three affiliated sites, including Georgia's only proton therapy center, the state's largest Phase I Clinical Trials Unit (400+ active trials, 850+ enrolled patients in 2025), and the first and largest bone marrow and stem cell transplant program in the state. Its research enterprise spans 689 members across 41 departments in 5 Emory schools plus Georgia Tech, with 175+ postdoctoral fellows and $133M in research grant funding for November 2024–October 2025.

Winship's revenue comes from three streams: patient care services (with hematology and medical oncology clinics operating through Emory University Hospital Midtown for billing); philanthropy and fundraising (cumulative Winship 5K proceeds of $12M+, record 2022 Gala of $1.85M, Fashion a Cure cumulatively above $3M, and a transformational 2018 $400M gift from the Robert W. Woodruff Foundation partly funding the Emory Midtown facility); and research grants and sponsored programs (NIH, NCI, CDC, American Cancer Society, Georgia Research Alliance — including a five-year, $12.1M NCI SPORE lymphoma grant awarded in 2025 in partnership with MD Anderson). Specific service pricing is not publicly disclosed; patients are directed to financial counselors and their insurer for cost estimates.

The institute's technology stack combines advanced therapeutic modalities (proton therapy, CAR T-cell, immunotherapy, targeted therapy, bone marrow and stem cell transplant) with proprietary AI tools: a first-of-its-kind AI platform for clinical trial matching that predicts individual patient response, an AI computational pathology tool for pre-invasive breast cancer integrating imaging and molecular data, and AI capabilities for cancer diagnosis and prognosis that address health disparities through population-specific imaging and pathology models. Distribution runs primarily through physician referrals (WinshipMD app, Emory Healthcare Link portal) and the Winship Cancer Network affiliations with community hospitals such as Hamilton Medical Center and Archbold Memorial, with a 2025-launched Mobile Prostate Cancer Screening Program extending community-based screening to underserved Georgia populations in partnership with Mount Sinai Health System and the Arthur M. Blank Family Foundation.

Name

Winship Cancer Institute of Emory University

Legal name

Winship Cancer Institute of Emory University

Website

https://winshipcancer.emory.edu

Company type

Private

Founded year

1937

Operating status

Operating

Headcount range

251–500 employees

Short description

Winship Cancer Institute of Emory University is Georgia's only NCI-designated Comprehensive Cancer Center, delivering prevention, treatment, clinical trials, and survivorship care to over 21,000 new patients annually across eight Emory Healthcare locations in metro Atlanta and the Southeast.

Ownership category

akta.pro rank

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Patient Care Services: Clinical care revenue from treating over 21,000 new patients annually across eight Emory Healthcare locations. Services include surgery, medical oncology, radiation oncology, bone marrow transplant, and supportive care. Hematology/medical oncology clinics operated by Emory University Hospital Midtown for billing purposes.
2. Philanthropy and Fundraising: Major donor contributions, planned gifts, annual fundraising events including Winship 5K (over $12 million raised to date), Winship Gala (record $1.85 million raised in 2022), and Friends of Winship organization. Robert W. Woodruff Foundation donated $400 million in 2018 with portion allocated to Winship.
3. Research Grants and Sponsored Programs: Cancer research supported by $133 million in grant funding (November 2024–October 2025). NCI SPORE grants including $12.1 million lymphoma SPORE with MD Anderson (2025). NCTN Lead Academic Participating Site designation. NIH, CDC, American Cancer Society, and Georgia Research Alliance funding.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels12 records

Core offering

Winship Cancer Institute provides comprehensive cancer care across the full continuum—prevention, detection, diagnosis, treatment, and survivorship—serving more than 21,000 new patients per year through eight Emory Healthcare locations in metro Atlanta. It operates Georgia's only NCI-designated Comprehensive Cancer Center, the state's only proton therapy center, the largest Phase I clinical trials unit in Georgia, and the first and largest bone marrow and stem cell transplant program in the state. Treatment offerings include surgery, medical oncology, radiation oncology (including proton therapy), CAR T-cell therapy, immunotherapy, targeted therapy, and supportive/palliative care, supported by over 400 active clinical trials.

Product overview

Winship Cancer Institute of Emory University is Georgia's only NCI-designated Comprehensive Cancer Center offering a comprehensive portfolio of cancer care services. The core offering includes clinical care across eight Emory Healthcare locations, with flagship facilities including the Phase I Clinical Trials Unit (largest in Georgia), Emory Proton Therapy Center (only in state), and Bone Marrow and Stem Cell Transplant Program (first and largest in Georgia). Specialized sub-brands include Winship Cancer Institute at Emory Midtown (opened 2023), Mobile Prostate Cancer Screening Program, Glenn Family Breast Center, Palliative Medicine Program, and Rollins Immediate Care Center. The institution also operates the Winship Cancer Network (community hospital partnerships) and provides technology tools including the WinshipMD physician directory app and Emory Healthcare Link referral portal.

Differentiator

Problem solved

Functional benefit

Brands

• WinshipMD: Physician directory app for physicians and advanced practice providers to search for Winship physicians by name, location or treatment specialty and gain access to their direct contact information
• Glenn Family Breast Center
• Emory Proton Therapy Center
• Winship Cancer Network
• Winship Cancer Institute at Emory Midtown

Products and services

• Winship Cancer Institute of Emory University
• Phase I Clinical Trials Unit
• Emory Proton Therapy Center
• Bone Marrow and Stem Cell Transplant Program
• Winship Cancer Institute at Emory Midtown
• Mobile Prostate Cancer Screening Program
• Winship Cancer Network
• Rollins Immediate Care Center
• Glenn Family Breast Center
• Palliative Medicine Program
• WinshipMD App
• Emory Healthcare Link

Quantifiable outcome

• Chances of surviving cancer are up to 25% higher when starting treatment at an NCI-designated Comprehensive Cancer Center
• +3 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature5 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• MD Anderson Cancer CentercoreStrategic or Co-development Partner · 1 January 2025Collaboration on a five-year, $12.1 million NCI SPORE grant focused on improving outcomes for patients with lymphoma. Winship leads the multi-institutional initiative in partnership with MD Anderson as part of a strategic effort to advance translational research in hematologic malignancies.
• Hamilton Medical CenterminorStrategic or Co-development PartnerCommunity hospital partner in the Winship Cancer Network. Located at 1200 Memorial Drive, Dalton, GA 30722. Affiliation provides access to Winship's multidisciplinary tumor boards, clinical trials, CME/CE opportunities, and quality assurance programs.
• Lewis Hall Singletary Oncology Center at Archbold Memorial HospitalminorStrategic or Co-development PartnerCommunity hospital partner in the Winship Cancer Network. Located at 915 Gordon Avenue, Thomasville, GA 31792. First partner joined in 2016. Affiliation provides clinical research collaboration, education, and quality assurance with Winship.
• Mount Sinai Health SystemcoreStrategic or Co-development PartnerCollaboration on the Winship Mobile Prostate Cancer Screening Program. Building on the success of Mount Sinai's Robert F. Smith Mobile Prostate Cancer Screening Program, this collaboration adapts the model to reach underserved communities across Georgia, expanding access to prostate cancer screening.
• Georgia Center for Oncology Research and Education (GeorgiaCore)coreStrategic or Co-development PartnerPartnership with GeorgiaCore to expand availability of cancer clinical trials throughout Georgia. Works with community-based physicians to extend Winship's research capabilities beyond its own facilities.
• Georgia TechcoreStrategic or Co-development PartnerJoint research collaboration with Georgia Tech as part of Winship's 689 research members from 41 departments across 5 Emory schools plus partner institutions. Includes joint programs in cancer nanotechnology and computational/biomedical research.
• MAIA BiotechnologyminorStrategic or Co-development PartnerMAIA Biotechnology activated Winship Cancer Institute of Emory University as a clinical trial site for the Phase II THIO-101 trial evaluating ateganosine as third-line therapy for non-small cell lung cancer. Winship is the third U.S. site in this multi-centre study. Earlier phases showed early efficacy with some patients exceeding two years of survival.
• BriaCell TherapeuticsminorStrategic or Co-development PartnerBriaCell added Winship Cancer Institute of Emory University as a key clinical site in its Phase 3 clinical trial in metastatic breast cancer. The trial involves 79 sites evaluating Bria-IMT plus immune checkpoint inhibitors compared to physician's choice treatment, with top-line results expected first half of 2026.
• National Cancer Institute (NCI) National Clinical Trials NetworkcoreStrategic or Co-development PartnerWinship is one of 30 inaugural U.S. cancer centers selected as a Lead Academic Participating Site for the NCI's National Clinical Trials Network, the NCI's primary infrastructure to conduct phase 2 and 3 clinical trials.

Scale indicators18 records

Recent moves13 records

Expansion highlights6 records

Direct peers

• MD Anderson Cancer Center: The University of Texas MD Anderson Cancer Center is the largest and one of the most prominent NCI-designated Comprehensive Cancer Centers in the U.S. It is Winship's most direct academic peer in NCI designation, Phase I trial volume, SPORE grants, and clinical-research integration — and is currently a Winship collaborator on the lymphoma SPORE.
• Memorial Sloan Kettering Cancer Center: Memorial Sloan Kettering is a top NCI-designated Comprehensive Cancer Center with a national referral base and clinical research portfolio directly comparable to Winship. MSK is also a key competitor for Winship's senior recruits (e.g., Chief Surgical Officer Tari King was recruited from MSK).
• UCSF Helen Diller Family Comprehensive Cancer Center: UCSF Helen Diller is an NCI-designated Comprehensive Cancer Center with a research and clinical portfolio comparable to Winship, particularly in translational science, Phase I trials, and precision oncology AI.
• Vanderbilt-Ingram Cancer Center: Vanderbilt-Ingram is an NCI-designated Comprehensive Cancer Center affiliated with Vanderbilt University Medical Center. It is comparable to Winship in academic medical center structure, NCI research portfolio, and regional referral model across the Southeast.
• Roswell Park Comprehensive Cancer Center: Roswell Park in Buffalo, NY is an NCI-designated Comprehensive Cancer Center and the nation's first cancer research center. Comparable to Winship in mission, scale, research funding base, and Phase I clinical trials focus.
• Duke Cancer Institute: Duke Cancer Institute is an NCI-designated Comprehensive Cancer Center at Duke University. Comparable to Winship in university-based structure, clinical trial network participation (NCTN LAP), and Southeast U.S. academic oncology competition.
• Fred Hutchinson Cancer Center: Fred Hutchinson (formerly Fred Hutchinson Cancer Research Center, now unified with UW Medicine) is an NCI-designated Comprehensive Cancer Center with world-leading bone marrow transplant, immunotherapy, and Phase I programs directly comparable to Winship's flagship clinical services.
• Dana-Farber Cancer Institute: Dana-Farber, affiliated with Harvard, is an NCI-designated Comprehensive Cancer Center and a leader in Phase I trials, hematologic malignancies, and translational research. It competes with Winship for talent (Tari King was also recruited from Dana-Farber), federal funding, and lymphoma/myeloma referrals.
• H. Lee Moffitt Cancer Center & Research Institute: Moffitt is an NCI-designated Comprehensive Cancer Center based in Tampa, Florida. It is one of the closest geographic and scale peers to Winship, with a comparable mix of clinical care, Phase I trials, and translational research serving the Southeast U.S.

Broad incumbents

• Emory Healthcare: Emory Healthcare is Winship's parent health system and primary operator of clinical facilities, billing, and MyChart. Emory Healthcare provides the broader hospital infrastructure (eight locations including Emory University Hospital Midtown) within which Winship operates its specialty oncology programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/winshipatemory
• YouTubeyoutube.com/user/WinshipCancer
• Facebookfacebook.com/winshipfightscancer
• LinkedInlinkedin.com/company/winship-cancer-institute
• Instagraminstagram.com/winshipatemory

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Winship Cancer Institute of Emory University